Haprolid Inhibits Tumor Growth of Hepatocellular Carcinoma through Rb/E2F and Akt/mTOR Inhibition

Background: Hepatocellular carcinoma (HCC) represents a major health burden with limited curative treatment options. There is a substantial unmet need to develop innovative approaches to impact the progression of advanced HCC. Haprolid is a novel natural component isolated from myxobacteria. Haproli...

Descripción completa

Detalles Bibliográficos
Autores principales: Xing, Jun, Bhuria, Vikas, Bui, Khac Cuong, Nguyen, Mai Ly Thi, Hu, Zexi, Hsieh, Chih-Jen, Wittstein, Kathrin, Stadler, Marc, Wilkens, Ludwig, Li, Jun, Kalesse, Markus, Bozko, Przemyslaw, Plentz, Ruben R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139901/
https://www.ncbi.nlm.nih.gov/pubmed/32155915
http://dx.doi.org/10.3390/cancers12030615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139901/
https://www.ncbi.nlm.nih.gov/pubmed/32155915
http://dx.doi.org/10.3390/cancers12030615

Ejemplares similares